[Federal Register Volume 87, Number 205 (Tuesday, October 25, 2022)]
[Notices]
[Pages 64459-64460]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23096]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID: DoD-2022-HA-0076]


Submission for OMB Review; Comment Request

AGENCY: Office of the Assistant Secretary of Defense Health Affairs, 
Department of Defense (DoD).

ACTION: 30-Day information collection notice.

-----------------------------------------------------------------------

SUMMARY: The DoD has submitted to the Office of Management and Budget 
(OMB) for clearance the following proposal for collection of 
information under the provisions of the Paperwork Reduction Act.

DATES: Consideration will be given to all comments received by November 
25, 2022.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Angela Duncan, 571-372-7574, [email protected].

SUPPLEMENTARY INFORMATION: 
    Title; Associated Form; and OMB Number: Federal Agency Retail 
Pharmacy Program; OMB Control Number 0720-0032.
    Type of Request: Revision.
    Number of Respondents: 300.
    Responses per Respondent: 4.
    Annual Responses: 1,200.
    Average Burden per Response: 8 hours.
    Annual Burden Hours: 9,600 hours.
    Needs and Uses: The information collection requirement is necessary 
to obtain and record refund amounts between the DoD and pharmaceutical 
manufacturers. The DoD quarterly provides pharmaceutical manufacturers 
with itemized utilization data on covered drugs dispensed to TRICARE 
beneficiaries through TRICARE retail network pharmacies. These 
manufacturers validate the refund

[[Page 64460]]

amounts calculated from the difference in price between the Federal 
Ceiling Prices and the direct commercial contract sales price. Once the 
refund amounts are validated, the pharmaceutical manufacturers directly 
pay the Defense Health Agency Government account.
    Affected Public: Businesses or other for profit.
    Frequency: On occasion.
    Respondent's Obligation: Voluntary.
    OMB Desk Officer: Ms. Jasmeet Seehra.
    You may also submit comments and recommendations, identified by 
Docket ID number and title, by the following method:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
    Instructions: All submissions received must include the agency 
name, Docket ID number, and title for this Federal Register document. 
The general policy for comments and other submissions from members of 
the public is to make these submissions available for public viewing on 
the internet at http://www.regulations.gov as they are received without 
change, including any personal identifiers or contact information.
    DOD Clearance Officer: Ms. Angela Duncan.
    Requests for copies of the information collection proposal should 
be sent to Ms. Duncan at [email protected].

    Dated: October 19, 2022.
Kayyonne T. Marston,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2022-23096 Filed 10-24-22; 8:45 am]
BILLING CODE 5001-06-P